{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:33:12Z","timestamp":1789399992434,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41433-020-1109-4","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T15:03:51Z","timestamp":1595862231000},"page":"1326-1333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3854-1617","authenticated-orcid":false,"given":"Bhupesh","family":"Bagga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi Pratap Singh","family":"Gour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-4930","authenticated-orcid":false,"given":"Ashik","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-1977","authenticated-orcid":false,"given":"Joveeta","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"M Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-2815","authenticated-orcid":false,"given":"Prashant","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"1109_CR1","doi-asserted-by":"crossref","unstructured":"Carnt N, Robaei D, Minassian DC, Dart JKG. Acanthamoeba keratitis in 194 patients: risk factors for bad outcomes and severe inflammatory complications. Br J Ophthalmol. 2018;102:1431\u201335.","DOI":"10.1136\/bjophthalmol-2017-310806"},{"key":"1109_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajo.2009.06.009","volume":"148","author":"JK Dart","year":"2009","unstructured":"Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148:487\u201399 e2.","journal-title":"Am J Ophthalmol"},{"key":"1109_CR3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/bjo.84.10.1103","volume":"84","author":"S Sharma","year":"2000","unstructured":"Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol. 2000;84:1103\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1109_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/02713689608997418","volume":"15","author":"J Tirado-Angel","year":"1996","unstructured":"Tirado-Angel J, Gabriel MM, Wilson LA, Ahearn DG. Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro. Curr Eye Res. 1996;15:225\u20138.","journal-title":"Curr Eye Res"},{"key":"1109_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00003226-200203000-00016","volume":"21","author":"S Narasimhan","year":"2002","unstructured":"Narasimhan S, Madhavan HN, K LT. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea. 2002;21:203\u20135.","journal-title":"Cornea"},{"key":"1109_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1550-7408.2005.00082.x","volume":"53","author":"FL Schuster","year":"2006","unstructured":"Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006;53:121\u20136.","journal-title":"J Eukaryot Microbiol"},{"key":"1109_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1600-0420.2004.00237.x","volume":"82","author":"N Ehlers","year":"2004","unstructured":"Ehlers N, Hjortdal J. Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis? Acta Ophthalmol Scand. 2004;82:228\u201331.","journal-title":"Acta Ophthalmol Scand"},{"key":"1109_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ophtha.2007.05.054","volume":"115","author":"NL Herz","year":"2008","unstructured":"Herz NL, Matoba AY, Wilhelmus KR. Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology. 2008;115:866\u20139.","journal-title":"Ophthalmology"},{"key":"1109_CR9","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0161-6420(97)30092-X","volume":"104","author":"IG Duguid","year":"1997","unstructured":"Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, et al. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997;104:1587\u201392.","journal-title":"Ophthalmology"},{"key":"1109_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0039-6257(98)00004-6","volume":"42","author":"CD Illingworth","year":"1998","unstructured":"Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol. 1998;42:493\u2013508.","journal-title":"Surv Ophthalmol"},{"key":"1109_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ajo.2005.07.031","volume":"140","author":"ST Awwad","year":"2005","unstructured":"Awwad ST, Parmar DN, Heilman M, Bowman RW, McCulley JP, Cavanagh HD. Results of penetrating keratoplasty for visual rehabilitation after Acanthamoeba keratitis. Am J Ophthalmol. 2005;140:1080\u20134.","journal-title":"Am J Ophthalmol"},{"key":"1109_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/ICO.0b013e3181131ea9","volume":"26","author":"A Parthasarathy","year":"2007","unstructured":"Parthasarathy A, Tan DT. Deep lamellar keratoplasty for acanthamoeba keratitis. Cornea. 2007;26:1021\u20133.","journal-title":"Cornea"},{"key":"1109_CR13","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3201\/eid1411.070854","volume":"14","author":"AC Aichelburg","year":"2008","unstructured":"Aichelburg AC, Walochnik J, Assadian O, Prosch H, Steuer A, Perneczky G, et al. Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine. Emerg Infect Dis. 2008;14:1743\u20136.","journal-title":"Emerg Infect Dis"},{"key":"1109_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4103\/ijo.IJO_307_19","volume":"68","author":"B Bagga","year":"2020","unstructured":"Bagga B, Garg P, Joseph J, Mohamed A, Kalra P. Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis. Indian J Ophthalmol. 2020;68:442\u20136.","journal-title":"Indian J Ophthalmol"},{"key":"1109_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jcjo.2012.03.040","volume":"47","author":"I Kaiserman","year":"2012","unstructured":"Kaiserman I, Bahar I, McAllum P, Srinivasan S, Elbaz U, Slomovic AR, et al. Prognostic factors in Acanthamoeba keratitis. Can J Ophthalmol. 2012;47:312\u20137.","journal-title":"Can J Ophthalmol"},{"key":"1109_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jac\/dkp215","volume":"64","author":"J Walochnik","year":"2009","unstructured":"Walochnik J, Obwaller A, Gruber F, Mildner M, Tschachler E, Suchomel M, et al. Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent. J Antimicrob Chemother. 2009;64:539\u201345.","journal-title":"J Antimicrob Chemother"},{"key":"1109_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/ICO.0b013e3181cbfa2c","volume":"29","author":"EY Tu","year":"2010","unstructured":"Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy. Cornea. 2010;29:1066\u20138.","journal-title":"Cornea"},{"key":"1109_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.clae.2011.06.004","volume":"34","author":"S Gupta","year":"2011","unstructured":"Gupta S, Shrivastava RM, Tandon R, Gogia V, Agarwal P, Satpathy G. Role of voriconazole in combined acanthamoeba and fungal corneal ulcer. Cont Lens Anterior Eye. 2011;34:287\u20139.","journal-title":"Cont Lens Anterior Eye"},{"key":"1109_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00436-011-2515-0","volume":"110","author":"ZA Polat","year":"2012","unstructured":"Polat ZA, Obwaller A, Vural A, Walochnik J. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters. Parasitol Res. 2012;110:515\u201320.","journal-title":"Parasitol Res"},{"key":"1109_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00436-013-3705-8","volume":"113","author":"AM Cabello-Vilchez","year":"2014","unstructured":"Cabello-Vilchez AM, Martin-Navarro CM, Lopez-Arencibia A, Reyes-Batlle M, Sifaoui I, Valladares B, et al. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru. Parasitol Res. 2014;113:755\u20139.","journal-title":"Parasitol Res"},{"key":"1109_CR21","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1128\/AAC.00066-15","volume":"59","author":"CM Martin-Navarro","year":"2015","unstructured":"Martin-Navarro CM, Lopez-Arencibia A, Sifaoui I, Reyes-Batlle M, Valladares B, Martinez-Carretero E, et al. Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii. Antimicrob Agents Chemother. 2015;59:2817\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"1109_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1099\/jmm.0.000103","volume":"64","author":"P Rocha-Cabrera","year":"2015","unstructured":"Rocha-Cabrera P, Reyes-Batlle M, Martin-Navarro CM, Dorta-Gorrin A, Lopez-Arencibia A, Sifaoui I, et al. Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains. J Med Microbiol. 2015;64:849\u201353.","journal-title":"J Med Microbiol"},{"key":"1109_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajo.2009.08.004","volume":"149","author":"S Bang","year":"2010","unstructured":"Bang S, Edell E, Eghrari AO, Gottsch JD. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Am J Ophthalmol. 2010;149:66\u20139.","journal-title":"Am J Ophthalmol"},{"key":"1109_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4103\/tjo.tjo_55_17","volume":"7","author":"TY Hou","year":"2017","unstructured":"Hou TY, Chen YC, Hsu CC. Rapid resolution of stromal keratitis with the assistance of oral voriconazole in resistant acanthamoeba keratitis. Taiwan J Ophthalmol. 2017;7:224\u20136.","journal-title":"Taiwan J Ophthalmol"},{"key":"1109_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25:1057\u201373.","journal-title":"Stat Methods Med Res"},{"key":"1109_CR26","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/sim.4780141709","volume":"14","author":"RH Browne","year":"1995","unstructured":"Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933\u201340.","journal-title":"Stat Med"},{"key":"1109_CR27","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1007\/s10792-019-01134-4","volume":"39","author":"YE Wang","year":"2019","unstructured":"Wang YE, Tepelus TC, Vickers LA, Baghdasaryan E, Gui W, Huang P, et al. Role of in vivo confocal microscopy in the diagnosis of infectious keratitis. Int Ophthalmol. 2019;39:2865\u201374.","journal-title":"Int Ophthalmol"},{"key":"1109_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"1109_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/bjo.2007.121715","volume":"92","author":"DA Laidlaw","year":"2008","unstructured":"Laidlaw DA, Tailor V, Shah N, Atamian S, Harcourt C. Validation of a computerised logMAR visual acuity measurement system (COMPlog): comparison with ETDRS and the electronic ETDRS testing algorithm in adults and amblyopic children. Br J Ophthalmol. 2008;92:241\u20134.","journal-title":"Br J Ophthalmol"},{"key":"1109_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4103\/ijo.IJO_826_17","volume":"65","author":"P Garg","year":"2017","unstructured":"Garg P, Kalra P, Joseph J. Non-contact lens related Acanthamoeba keratitis. Indian J Ophthalmol. 2017;65:1079\u201386.","journal-title":"Indian J Ophthalmol"},{"key":"1109_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1345\/aph.1C261","volume":"37","author":"MM Pearson","year":"2003","unstructured":"Pearson MM, Rogers PD, Cleary JD, Chapman SW. Voriconazole: a new triazole antifungal agent. Ann Pharmacother. 2003;37:420\u201332.","journal-title":"Ann Pharmacother"},{"key":"1109_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/ICO.0000000000001781","volume":"38","author":"N Sharma","year":"2019","unstructured":"Sharma N, Sahay P, Maharana PK, Singhal D, Saluja G, Bandivadekar P, et al. Management algorithm for fungal keratitis: the TST (Topical, Systemic, and Targeted Therapy) protocol. Cornea. 2019;38:141\u20135.","journal-title":"Cornea"},{"key":"1109_CR33","doi-asserted-by":"crossref","unstructured":"Gueudry J, Le Goff L, Compagnon P, Lefevre S, Colasse E, Aknine C, et al. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis. J Antimicrob Chemother. 2018;73:1895\u20138.","DOI":"10.1093\/jac\/dky094"},{"key":"1109_CR34","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/ICO.0000000000002055","volume":"38","author":"M Talbott","year":"2019","unstructured":"Talbott M, Cevallos V, Chen MC, Chin SA, Lalitha P, Seitzman GD, et al. Synergy testing of antiamoebic agents for acanthamoeba: antagonistic effect of voriconazole. Cornea. 2019;38:1309\u201313.","journal-title":"Cornea"},{"key":"1109_CR35","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.ophtha.2014.04.013","volume":"121","author":"A Sunada","year":"2014","unstructured":"Sunada A, Kimura K, Nishi I, Toyokawa M, Ueda A, Sakata T, et al. In vitro evaluations of topical agents to treat Acanthamoeba keratitis. Ophthalmology. 2014;121:2059\u201365.","journal-title":"Ophthalmology"},{"key":"1109_CR36","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/ctr.12834","volume":"30","author":"MT Levine","year":"2016","unstructured":"Levine MT, Chandrasekar PH. Adverse effects of voriconazole: over a decade of use. Clin Transplant. 2016;30:1377\u201386.","journal-title":"Clin Transplant"},{"key":"1109_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archophthalmol.2007.71","volume":"126","author":"D Lau","year":"2008","unstructured":"Lau D, Fedinands M, Leung L, Fullinfaw R, Kong D, Davies G, et al. Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study. Arch Ophthalmol. 2008;126:343\u20136.","journal-title":"Arch Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1109-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1109-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1109-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:12:48Z","timestamp":1684602768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-1109-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1109"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-1109-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}